MYC and hepatocellular carcinoma: In order to investigate the molecular mechanisms underlying the combined therapeutic effect of Sor and PGV-1, we assessed the expression levels of c-Myc protein in HCC cells treated with the drugs using Western blot (Supporting Figure 1).